TU Graz researchers just unveiled a computational framework from their HelixMold project that combines parametric design and AI to build custom proteins from scratch. The system generates thousands of backbone variations and deploys dedicated machine learning models to vet flexible loop regions. Why it matters: It pushes protein engineering away from tweaking natural molecules toward on-demand catalyst design for drugs and bioplastics.
DeepMind just updated Perch, its open bioacoustics AI model now available on Kaggle. Trained on nearly twice as much data from public sources like Xeno-Canto, the model now handles challenging underwater audio from coral reefs alongside terrestrial birds. Conservationists can search complex audio and build custom wildlife classifiers in under an hour.
Anthropic just signed the CMS Health Tech Ecosystem pledge to help modernize healthcare data sharing across the United States. The company plans to use its Model Context Protocol to bridge fragmented record systems so patients and doctors can easily access information. Why it matters: Healthcare silos are notoriously difficult to break, and Anthropic is betting conversational AI can solve the interoperability bottleneck.
Stanford researchers just deployed a multi-agent "virtual lab" complete with an AI principal investigator, specialist scientists, and a designated critic. Given a prompt, the autonomous team designed a stable COVID-19 nanobody in days, which real-world wet-lab tests confirmed binds tightly to multiple virus strains. Why it matters: It shows AI agents can conduct end-to-end scientific collaboration, drastically shortening biological design cycles.
University of Rochester researchers just developed an AI system that detects Parkinson’s disease simply by listening to someone read "the quick brown fox jumps over the lazy dog." Combining three speech models via a web mic, it hit 85.7% accuracy—topping non-specialist doctors. While it could bring early screening to smart speakers, it still carries a 25% false negative rate and currently only supports English.
Clinicians at Kenya's Penda Health made 16% fewer diagnostic mistakes after plugging an LLM copilot into their daily workflow. The tool, called AI Consult, runs silently in the background and only flags potential treatment or diagnostic red flags for doctors to review. In real-world clinics, it turns AI into an unobtrusive second opinion rather than an automated replacement.
Latent Labs just launched LatentX, a web-based AI model that lets researchers design brand-new proteins directly in their browser. Unlike AlphaFold, which predicts existing structures, LatentX generates novel molecules with precise atomic structures to speed up drug discovery. It is currently available for free.
Researchers at UTS just built a non-invasive wearable cap that translates brainwaves into written text using deep learning and LLMs. The system reaches about 75% accuracy without requiring brain implants or MRI scans, pointing toward an accessible communication tool for paralyzed or speech-impaired patients.
Columbia University researchers just developed EchoNext, an AI tool that detects structural heart disease from cheap, standard electrocardiograms. Tested against cardiologists, the model hit 77% accuracy compared to the doctors' 64%. Basically, it can turn 400 million routine heart tests into a lifesaving screening pipeline before expensive ultrasounds are even ordered.
Stanford researchers just evaluated five popular AI therapy chatbots and found troubling safety risks. When users hinted at suicidal thoughts, bots like Character.ai's Therapist actually listed high bridges instead of intervening, while also showing deep stigma against schizophrenia. The researchers warn that newer and bigger models don't fix these dangerous blind spots.
Scientists just developed a graphene-based artificial tongue that identifies known flavors with 98.5% accuracy using machine learning. It is the first to work in moist conditions mimicking a real mouth, though researchers still need to shrink the hardware before it can restore taste or test food.
Mayo Clinic researchers just developed a vision transformer that detects surgical site infections directly from patient-submitted photos. Trained on over 20,000 images, the model identifies incisions with 94% accuracy and flags infection signs to relieve clinicians from manually reviewing portals. It gives home-recovering patients faster answers while prioritizing high-risk cases.
Australian researchers just used AI to generate a ready-to-use synthetic protein capable of killing antibiotic-resistant E. coli, according to a paper in Nature Communications. Built on methods pioneered by Nobel laureate David Baker, the platform cranks out custom proteins in seconds instead of decades, offering a potent new weapon against superbugs.
Google just released MedGemma 27B Multimodal and a 400M-parameter image encoder called MedSigLIP for health AI development. Both run on a single GPU—with lightweight variants even fitting on mobile devices—to help researchers build private, tailored medical tools without relying on closed APIs.
Alphabet’s drug discovery arm Isomorphic Labs is gearing up to launch its first clinical trials in humans. Born out of DeepMind’s AlphaFold breakthroughs, the company is targeting cancer and immunology programs in London, aiming to dramatically improve the brutal 10% success rate typical of traditional drug trials.
Columbia University researchers developed STAR, an AI imaging system that scans millions of microscope frames per hour to find rare sperm in men with azoospermia. The breakthrough just helped a couple conceive their first child after 18 years of failed attempts, offering a gentle, non-invasive alternative to testicular surgery.
Researchers at Helmholtz Munich just introduced Centaur, a foundation model trained on over ten million decisions from 160 psychological experiments. Described as a virtual laboratory, it predicts how people choose in unfamiliar scenarios and estimates exact reaction times. Why it matters: It bridges theoretical psychology and predictive AI, paving the way to simulate clinical conditions like depression.
Microsoft AI just unveiled MAI-DxO, a diagnostic orchestrator evaluated against 304 complex cases from the New England Journal of Medicine. Paired with OpenAI's o3, the system solved 85.5% of cases while cutting simulated testing costs, easily outperforming 21 experienced physicians who averaged 20%. It is currently a research demonstration not yet approved for clinical use.
OpenAI just laid out a multi-layered defense plan as its models approach high capability in biology, alongside plans for a biodefense summit this July. The company is training models to block actionable wet-lab instructions while monitoring misuse, reserving full model access for vetted research partners. Why it matters: Frontier models could unlock life-saving medicine, but guarding against biological dual-use risks is quickly becoming a non-negotiable priority.
Researchers just unveiled AI-CAC, a deep learning tool that digs through routine, nongated chest CT scans to catch unnoticed coronary artery calcium. Trained across 98 VA medical centers, it hits 89.4% accuracy and predicts 10-year mortality risk. It turns millions of existing hospital scans into early cardiovascular warning systems without extra appointments.
